Lista de obras - P.vincent Jenkins - Dominio Público Uruguay

A recurrent F8 mutation in Irish haemophilia A patients: evidence for a founder effect

artículo científico publicado en 2007

ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?

artículo científico publicado en 2006

Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand disease

artículo científico publicado en 2001

Age-related factor IX correction in symptomatic female carriers with haemophilia B Leyden.

artículo científico publicado en 2015

Analysis of intron 22 inversions of the factor VIII gene in severe hemophilia A: implications for genetic counseling.

artículo científico publicado en 1994

Carrier detection and prenatal diagnosis by intron 22 inversion analysis of the factor VIII gene

artículo científico publicado en 1995

Clinical utility gene card for: haemophilia A.

artículo científico publicado en 2011

Clinical utility gene card for: haemophilia B.

artículo científico publicado en 2012

Clinical utility gene card for: von Willebrand disease

artículo científico publicado en 2011

Clustered basic residues within segment 484-510 of the factor VIIIa A2 subunit contribute to the catalytic efficiency for factor Xa generation.

artículo científico publicado en 2004

Comparison of a fluorogenic anti-FXa assay with a central laboratory chromogenic anti-FXa assay for measuring LMWH activity in patient plasmas

artículo científico publicado en 2011

Concentration-dependent roles for heparin in modifying liopolysaccharide-induced activation of mononuclear cells in whole blood

artículo científico publicado en 2008

Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase

artículo científico publicado en 2004

Elevated factor VIII levels and risk of venous thrombosis.

artículo científico publicado en 2012

Enzymatically oxidized phospholipids restore thrombin generation in coagulation factor deficiencies.

artículo científico publicado en 2018

Experience of immune tolerance in a carrier of severe haemophilia A with inhibitor development post-surgery.

artículo científico publicado en 2017

Factor VIII gene inversions in severe hemophilia A: results of an international consortium study.

artículo científico publicado en 1995

Galectin-1 and Galectin-3 Constitute Novel-Binding Partners for Factor VIII.

artículo científico publicado en 2016

Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients: a reappraisal using phenotypes, genotypes and molecular modelling.

artículo científico publicado en 2000

Intron 22 inversions and haemophilia

artículo científico publicado en 1994

Inversion mutation analysis in hemophilia a by restriction enzyme analysis and southern blotting

artículo científico publicado en 1999

Laboratory coagulation tests and emicizumab treatment A United Kingdom Haemophilia Centre Doctors' Organisation guideline

artículo científico publicado en 2019

Laboratory measurement of factor replacement therapies in the treatment of congenital haemophilia: A United Kingdom Haemophilia Centre Doctors' Organisation guideline

scientific article published on 17 December 2019

Lack of activated protein C resistance in healthy Hong Kong Chinese blood donors--correlation with absence of Arg506-Gln mutation of factor V gene

article

Low risk of inhibitor formation in haemophilia A patients following en masse switch in treatment to a third generation full length plasma and albumin-free recombinant factor VIII product (ADVATE®).

artículo científico publicado en 2011

Low-molecular weight and unfractionated heparins induce a downregulation of inflammation: decreased levels of proinflammatory cytokines and nuclear factor-kappaB in LPS-stimulated human monocytes

artículo científico publicado en 2006

Molecular modeling of ligand and mutation sites of the type A domains of human von Willebrand factor and their relevance to von Willebrand's disease.

artículo científico publicado en 1998

Multiplex PCR for Detection of the Prothrombin 3'-UTR (G20210A) Polymorphism and the Factor V Leiden Mutation

artículo científico publicado en 1999

Mutation analysis of haemophilia B in the Irish population: increased prevalence caused by founder effect

artículo científico publicado en 2008

Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complex

artículo científico publicado en 2002

Networks of enzymatically oxidized membrane lipids support calcium-dependent coagulation factor binding to maintain hemostasis.

artículo científico publicado en 2017

Phospholipid membranes drive abdominal aortic aneurysm development through stimulating coagulation factor activity

scientific article published on 03 April 2019

Platelet factor 4 impairs the anticoagulant activity of activated protein C.

artículo científico publicado en 2009

Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation

artículo científico publicado en 2009

Role of P1 residues Arg336 and Arg562 in the activated-Protein-C-catalysed inactivation of Factor VIIIa.

artículo científico publicado en 2006

Screening for Candidate Mutations Causing von Willebrand's Disease (vWD).

artículo científico publicado en 1999

Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition

artículo científico publicado en 2009

Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: Influence of glycosylation, proteolysis and gene mutations

article

The SARS-CoV2 envelope differs from host cells, exposes procoagulant lipids, and is disrupted in vivo by oral rinses

artículo científico publicado en 2022

The effects of the 32-bp CCR-5 deletion on HIV transmission and HIV disease progression in individuals with haemophilia

artículo científico publicado en 2000

Thrombin generation in haemophilia A patients with mutations causing factor VIII assay discrepancy

artículo científico publicado en 2010

Use of the collagen-binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assay

artículo científico publicado en 2002

Value of DNA analysis with multiple DNA probes for the detection of hemophilia A carriers.

artículo científico publicado en 1994

Will the 'true' factor level make itself known? Measuring factor therapy for treatment of hemophilia in the era of enhanced half-life products

artículo científico publicado en 2019

X-linked moyamoya syndrome associated with severe haemophilia A.

artículo científico publicado en 2015

Lista de obras de P.vincent Jenkins

A recurrent F8 mutation in Irish haemophilia A patients: evidence for a founder effect

ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?

Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand disease

Age-related factor IX correction in symptomatic female carriers with haemophilia B Leyden.

Analysis of intron 22 inversions of the factor VIII gene in severe hemophilia A: implications for genetic counseling.

Carrier detection and prenatal diagnosis by intron 22 inversion analysis of the factor VIII gene

Clinical utility gene card for: haemophilia A.

Clinical utility gene card for: haemophilia B.

Clinical utility gene card for: von Willebrand disease

Clustered basic residues within segment 484-510 of the factor VIIIa A2 subunit contribute to the catalytic efficiency for factor Xa generation.

Comparison of a fluorogenic anti-FXa assay with a central laboratory chromogenic anti-FXa assay for measuring LMWH activity in patient plasmas

Concentration-dependent roles for heparin in modifying liopolysaccharide-induced activation of mononuclear cells in whole blood

Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase

Elevated factor VIII levels and risk of venous thrombosis.

Enzymatically oxidized phospholipids restore thrombin generation in coagulation factor deficiencies.

Experience of immune tolerance in a carrier of severe haemophilia A with inhibitor development post-surgery.

Factor VIII gene inversions in severe hemophilia A: results of an international consortium study.

Galectin-1 and Galectin-3 Constitute Novel-Binding Partners for Factor VIII.

Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients: a reappraisal using phenotypes, genotypes and molecular modelling.

Intron 22 inversions and haemophilia

Inversion mutation analysis in hemophilia a by restriction enzyme analysis and southern blotting

Laboratory coagulation tests and emicizumab treatment A United Kingdom Haemophilia Centre Doctors' Organisation guideline

Laboratory measurement of factor replacement therapies in the treatment of congenital haemophilia: A United Kingdom Haemophilia Centre Doctors' Organisation guideline

Lack of activated protein C resistance in healthy Hong Kong Chinese blood donors--correlation with absence of Arg506-Gln mutation of factor V gene

Low risk of inhibitor formation in haemophilia A patients following en masse switch in treatment to a third generation full length plasma and albumin-free recombinant factor VIII product (ADVATE®).

Low-molecular weight and unfractionated heparins induce a downregulation of inflammation: decreased levels of proinflammatory cytokines and nuclear factor-kappaB in LPS-stimulated human monocytes

Molecular modeling of ligand and mutation sites of the type A domains of human von Willebrand factor and their relevance to von Willebrand's disease.

Multiplex PCR for Detection of the Prothrombin 3'-UTR (G20210A) Polymorphism and the Factor V Leiden Mutation

Mutation analysis of haemophilia B in the Irish population: increased prevalence caused by founder effect

Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complex

Networks of enzymatically oxidized membrane lipids support calcium-dependent coagulation factor binding to maintain hemostasis.

Phospholipid membranes drive abdominal aortic aneurysm development through stimulating coagulation factor activity

Platelet factor 4 impairs the anticoagulant activity of activated protein C.

Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation

Role of P1 residues Arg336 and Arg562 in the activated-Protein-C-catalysed inactivation of Factor VIIIa.

Screening for Candidate Mutations Causing von Willebrand's Disease (vWD).

Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition

Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: Influence of glycosylation, proteolysis and gene mutations

The SARS-CoV2 envelope differs from host cells, exposes procoagulant lipids, and is disrupted in vivo by oral rinses

The effects of the 32-bp CCR-5 deletion on HIV transmission and HIV disease progression in individuals with haemophilia

Thrombin generation in haemophilia A patients with mutations causing factor VIII assay discrepancy

Use of the collagen-binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assay

Value of DNA analysis with multiple DNA probes for the detection of hemophilia A carriers.

Will the 'true' factor level make itself known? Measuring factor therapy for treatment of hemophilia in the era of enhanced half-life products

X-linked moyamoya syndrome associated with severe haemophilia A.